DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma
Cellular Oncology · 2024
DOI: 10.1007/s13402-024-00917-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Rui Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong Province, China. Hauptthemen laut MEDLINE: DNA Methylation, Squamous Cell Carcinoma of Head and Neck, Immunophenotyping, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong Province, China.
- Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong Province, China. tangxran@163.com.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University
Zitieren
APA
Li, R., Wen, X., Lv, R. X., Ren, X. Y., Cheng, B. L., Wang, Y. K., Chen, R. Z., Hu, W., & Tang, X. R. (2024). DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma. Cellular Oncology. https://doi.org/10.1007/s13402-024-00917-x
Vancouver
Li R, Wen X, Lv RX, Ren XY, Cheng BL, Wang YK, et al. DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma. Cellular Oncology. 2024. doi:10.1007/s13402-024-00917-x
BibTeX
@article{Li2024,
author = {Li, Rui and Wen, Xin and Lv, Ru-Xue and Ren, Xian-Yue and Cheng, Bing-Lin and Wang, Yi-Kai and Chen, Ru-Zhen and Hu, Wen and Tang, Xin-Ran},
title = {DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma},
journal = {Cellular Oncology},
year = {2024},
doi = {10.1007/s13402-024-00917-x}
}
EUVIMED